Primary: adverse events | |||
---|---|---|---|
Study | Group ‐ within‐participant study | Event number | Total number of pairs of hands analysed |
Palmar hyperpigmentation | |||
Sezer 2007 | NB‐UVB | 0 | 12 |
Sezer 2007 | Local PUVA | 3 | 12 |
Primary: adverse events | |||
---|---|---|---|
Study | Group ‐ within‐participant study | Event number | Total number of pairs of hands analysed |
Palmar hyperpigmentation | |||
Sezer 2007 | NB‐UVB | 0 | 12 |
Sezer 2007 | Local PUVA | 3 | 12 |